IP Library › Assignment 030771/0530
Patent Assignment
Reel/Frame 030771/0530

Assignment of Assignor's Interest

Recorded: 2013-07-10 Pages: 3
Assignor
LY, TAI WEI
Executed: 2013-07-10
Assignee
ACTIMIS PHARMACEUTICALS, INC.
10835 ROAD TO THE CURE, SUITE 200, SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
Isotopically Enriched Pyrimidin-5-Yl Acetic Acid Derivatives as CRTH2 Antagonists
Patent: 8,541,419 →
Application: 13/061,921 →
Publication: US 2011/0172250
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest May 3, 2019
From: GOSSAMER BIO, INC.; GOSSAMER BIO SERVICES, INC.; GB001, INC.; GB002, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 049081/0335 →
Merger and Change of Name Jun 6, 2019
From: ACTIMIS PHARMACEUTICALS, INC.; GB007 MERGER SUB, INC.
To: GB007, INC.
Reel/Frame 049394/0181 →
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 49081/0335 May 3, 2024
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: GOSSAMER BIO, INC.; GOSSAMER BIO SERVICES, INC.; GB001, INC.; GB002, INC.
Reel/Frame 067310/0307 →